
FASN Inhibitor – TVB-2640
Indication – NASH
Phase 2
FASN Inhibitor – TVB-2640
Indication – Oncology
Phase 2
FASN Inhibitor – TVB-3567
Indication – Undisclosed
Preclinical
Posters & Publications
TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial
Gastroenterology
Read More